Martin Hils
Darmstadt, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Transcriptomic analysis of intestine following administration of a transglutaminase 2 inhibitor to prevent gluten-induced intestinal damage in celiac disease.
Journal: Nature immunology
Published: June 22, 2023
The Oral Transglutaminase 2 Inhibitor ZED1227 Accumulates in the Villous Enterocytes in Celiac Disease Patients during Gluten Challenge and Drug Treatment.
Journal: International journal of molecular sciences
Published: May 16, 2023
Features of ZED1227: The First-In-Class Tissue Transglutaminase Inhibitor Undergoing Clinical Evaluation for the Treatment of Celiac Disease.
Journal: Cells
Published: March 31, 2022
Editorial for the special issue on transglutaminases in translation - Novel tools and methods impacting on diagnostics and therapeutics.
Journal: Analytical biochemistry
Published: August 04, 2020
Nucleotide binding kinetics and conformational change analysis of tissue transglutaminase with switchSENSE.
Journal: Analytical biochemistry
Published: December 20, 2019
Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a).
Journal: Journal of thrombosis and haemostasis : JTH
Published: June 19, 2019
Response to Comment by Calderón de la Barca and Sigala-Robles on Microbial Transglutaminase Used in Bread Preparation at Standard Bakery Concentrations Does Not Increase Immunodetectable Amounts of Deamidated Gliadin.
Journal: Journal of agricultural and food chemistry
Published: December 28, 2017
Microbial Transglutaminase Used in Bread Preparation at Standard Bakery Concentrations Does Not Increase Immunodetectable Amounts of Deamidated Gliadin.
Journal: Journal of agricultural and food chemistry
Published: July 20, 2017
Microbial transglutaminase treatment in pasta-production does not affect the immunoreactivity of gliadin with celiac disease patients' sera.
Journal: Journal of agricultural and food chemistry
Published: July 08, 2014
Structure of active coagulation factor XIII triggered by calcium binding: basis for the design of next-generation anticoagulants.
Journal: Angewandte Chemie (International ed. in English)
Published: June 14, 2013
Differences in the inhibition of coagulation factor XIII-A from animal species revealed by Michael Acceptor- and thioimidazol based blockers.
Journal: Thrombosis research
Published: November 19, 2012
Last Updated: 09/26/2026